$23.780
-1.042 (-4.38%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ARQT Prediction & Forecast by Similar Chart Analysis
Alphio's ARQT stock price prediction model matches the current Arcutis Biotherapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $23.32 (-1.93%). The 1-week path is $23.24 (-2.25%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Arcutis Biotherapeutics, Inc. Stock?
Arcutis Biotherapeutics Inc is currently priced at $23.78, which is significantly below the analyst price targets of $34 and $35, indicating potential upside. However, the RSI is at a low 22.653, suggesting the stock is oversold, and there is a recent trend of insider selling increasing by 106.52%, which raises concerns about confidence in the stock. Given these factors, while there is potential for recovery, the current market sentiment and insider activity suggest holding rather than buying.
ARQT stock price ended at $23.78 on Friday, after losing -4.38%
Arcutis Biotherapeutics, Inc. (ARQT) last closed at $23.78, losing -4.38%. These facts feed the 1-day and 1-week ARQT price prediction above.
Forecast Drivers
Arcutis Biotherapeutics, Inc. (ARQT) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ARQT, ranked by similarity.
Seasonality analysis for ARQT
Historically the probability of a positive August return for ARQT is 61.90%. September offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ARQT
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $23.25 | $30.97 | $34.26 | +30.25% |
| Sep 2026 | $20.21 | $27.42 | $32.02 | +15.32% |
| Oct 2026 | $29.36 | $31.23 | $38.90 | +31.34% |
| Nov 2026 | $23.14 | $31.28 | $39.56 | +31.54% |
| Dec 2026 | $26.67 | $31.65 | $33.52 | +33.10% |
In 2026, Arcutis Biotherapeutics, Inc. (ARQT) is projected to range from $20.21 to $39.56.
Arcutis Biotherapeutics, Inc. 2026 monthly forecast
In Aug 2026, Arcutis Biotherapeutics, Inc. is projected to average $30.97, with a low of $23.25 and high of $34.26.
In Sep 2026, Arcutis Biotherapeutics, Inc. is projected to average $27.42, with a low of $20.21 and high of $32.02.
In Oct 2026, Arcutis Biotherapeutics, Inc. is projected to average $31.23, with a low of $29.36 and high of $38.90.
In Nov 2026, Arcutis Biotherapeutics, Inc. is projected to average $31.28, with a low of $23.14 and high of $39.56.
In Dec 2026, Arcutis Biotherapeutics, Inc. is projected to average $31.65, with a low of $26.67 and high of $33.52.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。